Status: Recruiting
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
This study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET/CT in stereotactic irradiated brain metastases from non-small cell lung cancer, melanoma and breast cancer.
Participants needed: 100
Trial details
Biological sex: AllType: InterventionalSponsor: The Netherlands Cancer InstituteUpdated: Apr 6, 2026Locations: 1
Eligibility criteria
Written informed consent [+3]
Known allergy to Ga68-PSMA [+4]